Literature DB >> 18778311

Role of increased penile expression of transforming growth factor-beta1 and activation of the Smad signaling pathway in erectile dysfunction in streptozotocin-induced diabetic rats.

Lu Wei Zhang1, Shuguang Piao, Min Ji Choi, Hwa-Yean Shin, Hai-Rong Jin, Woo Jean Kim, Sun U Song, Jee-Young Han, Seok Hee Park, Mizuko Mamura, Seong-Jin Kim, Ji-Kan Ryu, Jun-Kyu Suh.   

Abstract

INTRODUCTION: It has been suggested that transforming growth factor-beta1 (TGF-beta1) plays an important role in the pathogenesis of diabetes-induced erectile dysfunction. AIM: To investigate the expression and activity of Smad transcriptional factors, the key molecules for the initiation of TGF-beta-mediated fibrosis, in the penis of streptozotocin (STZ)-induced diabetic rats.
METHODS: Fifty-two 8-week-old Sprague-Dawley rats were used and divided into control and diabetic groups. Diabetes was induced by an intravenous injection of STZ. MAIN OUTCOME MEASURES: Eight weeks later, erectile function was measured by electrical stimulation of the cavernous nerve (N = 12 per group). The penis was harvested and stained with Masson trichrome or antibody to TGF-beta1, phospho-Smad2 (P-Smad2), smooth muscle alpha-actin, and factor VIII (N = 12 per group). Penis specimens from a separate group of animals were used for TGF-beta1 enzyme-linked immunosorbent assay (ELISA), P-Smad2/Smad2, phospho-Smad3 (P-Smad3)/Smad3, fibronectin, collagen I, and collagen IV western blot, or hydroxyproline determination.
RESULTS: Erectile function was significantly reduced in diabetic rats compared with that in controls. The expression of TGF-beta1, P-Smad2, and P-Smad3 protein evaluated by ELISA or western blot was higher in diabetic rats than in controls. Compared with that in control rats, P-Smad2 expression was higher mainly in smooth muscle cells and fibroblasts of diabetic rats, whereas no significant differences were noted in endothelial cells or in the dorsal nerve bundle. Cavernous smooth muscle and endothelial cell contents were lower in diabetic rats than in controls. Cavernous fibronectin, collagen IV, and hydroxyproline content was significantly higher in diabetic rats than in controls.
CONCLUSION: Upregulation of TGF-beta1 and activation of the Smad signaling pathway in the penis of diabetic rats might play important roles in diabetes-induced structural changes and deterioration of erectile function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778311     DOI: 10.1111/j.1743-6109.2008.00977.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  11 in total

Review 1.  Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis.

Authors:  Ahmed Mohamed Hassanin; Ahmed Zain Abdel-Hamid
Journal:  Int Urol Nephrol       Date:  2019-10-15       Impact factor: 2.370

2.  Fibrotic protein expression profiles in penile tissue of patients with erectile dysfunction.

Authors:  Marcelo R Cabrini; Sena F Sezen; Gwen Lagoda; Robert L Segal; Zhaoyong Feng; Cassio Andreoni; Arthur L Burnett
Journal:  Urology       Date:  2013-10       Impact factor: 2.649

3.  Inhibition of Ninjurin 1 restores erectile function through dual angiogenic and neurotrophic effects in the diabetic mouse.

Authors:  Guo Nan Yin; Min Ji Choi; Woo Jean Kim; Mi-Hye Kwon; Kang-Moon Song; Jin-Mi Park; Nando Dulal Das; Ki-Dong Kwon; Dulguun Batbold; Goo Taeg Oh; Gou Young Koh; Kyu-Won Kim; Ji-Kan Ryu; Jun-Kyu Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

4.  Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse.

Authors:  Hai-Rong Jin; Woo Jean Kim; Jae Sook Song; Shuguang Piao; Min Ji Choi; Munkhbayar Tumurbaatar; Sun Hwa Shin; Guo Nan Yin; Gou Young Koh; Ji-Kan Ryu; Jun-Kyu Suh
Journal:  Diabetes       Date:  2011-01-26       Impact factor: 9.461

5.  The pericyte as a cellular regulator of penile erection and a novel therapeutic target for erectile dysfunction.

Authors:  Guo Nan Yin; Nando Dulal Das; Min Ji Choi; Kang-Moon Song; Mi-Hye Kwon; Jiyeon Ock; Anita Limanjaya; Kalyan Ghatak; Woo Jean Kim; Jae Seog Hyun; Gou Young Koh; Ji-Kan Ryu; Jun-Kyu Suh
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

Review 6.  Research in pharmacotherapy for erectile dysfunction.

Authors:  Ji-Kan Ryu; Jun-Kyu Suh; Arthur L Burnett
Journal:  Transl Androl Urol       Date:  2017-04

7.  Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes.

Authors:  Jung Hun Oh; Sarah Kerns; Harry Ostrer; Simon N Powell; Barry Rosenstein; Joseph O Deasy
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

Review 8.  Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications.

Authors:  Linhao Xu; Yong Zhang; Jian Chen; Yizhou Xu
Journal:  J Diabetes Res       Date:  2020-06-11       Impact factor: 4.011

Review 9.  Reversion of penile fibrosis: Current information and a new horizon.

Authors:  Ahmed I El-Sakka
Journal:  Arab J Urol       Date:  2011-05-06

10.  Antioxidant and Antifibrotic Effect of a Herbal Formulation In Vitro and in the Experimental Andropause via Nrf2/HO-1 Signaling Pathway.

Authors:  Woong Jin Bae; Guan Qun Zhu; Sae Woong Choi; Hyun Cheol Jeong; Fahad Bashraheel; Kang Sup Kim; Su Jin Kim; Hyuk Jin Cho; U Syn Ha; Sung Hoo Hong; Ji Youl Lee; Hyun-A Oh; Hye Cheong Koo; Do Ram Kim; Sung Yeoun Hwang; Sae Woong Kim
Journal:  Oxid Med Cell Longev       Date:  2017-09-17       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.